Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2002 1
2003 1
2005 1
2006 1
2010 5
2011 3
2012 3
2013 7
2014 9
2015 15
2016 5
2017 3
2018 7
2019 11
2020 9
2021 16
2022 17
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 37097688

101 results

Results by year

Filters applied: . Clear all
Page 1
Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Kawahira M, Yokota T, Hamauchi S, Kawai S, Yoshida Y, Onozawa Y, Tsushima T, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H. Kawahira M, et al. Int J Clin Oncol. 2018 Dec;23(6):1189-1195. doi: 10.1007/s10147-018-1306-3. Epub 2018 Jun 15. Int J Clin Oncol. 2018. PMID: 29948238
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer. Aapro MS, et al. Eur J Cancer. 2011 Jan;47(1):8-32. doi: 10.1016/j.ejca.2010.10.013. Epub 2010 Nov 20. Eur J Cancer. 2011. PMID: 21095116
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia.
Căinap C, Cetean-Gheorghe S, Pop LA, Leucuta DC, Piciu D, Mester A, Vlad C, Ovidiu C, Gherman A, Crişan C, Bereanu A, Bălăcescu O, Constantin AM, Dicu I, Bălăcescu L, Stan A, Achimaş-Cadariu P, Căinap S. Căinap C, et al. Medicina (Kaunas). 2021 Jun 30;57(7):675. doi: 10.3390/medicina57070675. Medicina (Kaunas). 2021. PMID: 34208815 Free PMC article.
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.
Sakurada T, Bando S, Zamami Y, Takechi K, Chuma M, Goda M, Kirino Y, Nakamura T, Teraoka K, Morimoto M, Tangoku A, Ishizawa K. Sakurada T, et al. Cancer Chemother Pharmacol. 2019 Nov;84(5):1107-1114. doi: 10.1007/s00280-019-03948-6. Epub 2019 Sep 9. Cancer Chemother Pharmacol. 2019. PMID: 31502114
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Rossini D, Boccaccino A, Sbrana A, Daniel F, Borelli B, Raimondi A, Santini D, Conca V, Tomasello G, Caponnetto S, Marmorino F, Zaniboni A, Buonadonna A, Masi G, Lonardi S, Pietrantonio F, Falcone A, Antonuzzo A, Cremolini C. Rossini D, et al. ESMO Open. 2021 Dec;6(6):100293. doi: 10.1016/j.esmoop.2021.100293. Epub 2021 Oct 22. ESMO Open. 2021. PMID: 34689001 Free PMC article.
101 results